The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Janus Henderson Global Life Sciences I JFNIX Fund Analysis
Morningstar’s Analysis JFNIX
Will JFNIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar